Domain Therapeutics is granted European and US patent for biosensors assessing GPCR trafficking
Minoryx Therapeutics receives US FDA fast-track designation for leriglitazone in the treatment of X-ALD
Minoryx Therapeutics receives Orphan Drug Designation from the European Commission for leriglitazone in the treatment of Friedreich’s Ataxia
Minoryx Therapeutics receives FDA Orphan Drug Designation for leriglitazone in Friedreich’s Ataxia
CarThera receives FDA approval for Phase 1/2a trial in glioblastoma
PDC*line Pharma obtains authorization to launch phase I/II trial of its cancer vaccine (PDC*lung01) in non-small cell lung cancer
SafeHeal obtains CE-mark for Colovac, its novel endoluminal bypass sheath
Tetrahedron receives ‘Novel Food’ status for Ergoneine™, its unique-form L-ergothioneine
